Afrocentric Investment (JSE:ACT) 3-Year Revenue Growth Rate : 9.30% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment 3-Year Revenue Growth Rate?

Afrocentric Investment's Revenue per Share for the six months ended in Dec. 2023 was R5.18.

During the past 12 months, Afrocentric Investment's average Revenue per Share Growth Rate was -17.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 14.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Afrocentric Investment was 21.90% per year. The lowest was -1.90% per year. And the median was 13.90% per year.

Competitive Comparison of Afrocentric Investment's 3-Year Revenue Growth Rate

For the Medical Care Facilities subindustry, Afrocentric Investment's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Afrocentric Investment's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's 3-Year Revenue Growth Rate falls into.

Afrocentric Investment 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Afrocentric Investment (JSE:ACT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Afrocentric Investment 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Afrocentric Investment (JSE:ACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Conrad Road, Florida North, Roodepoort, ZAF, 1709

Website

http://www.afrocentric.za.com

Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.